HK1192322A1 - Determination of the efficacy of an anti mycobacterial vaccination - Google Patents

Determination of the efficacy of an anti mycobacterial vaccination

Info

Publication number
HK1192322A1
HK1192322A1 HK14105616.7A HK14105616A HK1192322A1 HK 1192322 A1 HK1192322 A1 HK 1192322A1 HK 14105616 A HK14105616 A HK 14105616A HK 1192322 A1 HK1192322 A1 HK 1192322A1
Authority
HK
Hong Kong
Prior art keywords
efficacy
determination
vaccination
anti mycobacterial
mycobacterial vaccination
Prior art date
Application number
HK14105616.7A
Other languages
English (en)
Chinese (zh)
Inventor
．德塞爾
．考夫曼
．班德曼
．格羅德
Original Assignee
馬普科技促進協會
疫苗項目管理有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 馬普科技促進協會, 疫苗項目管理有限公司 filed Critical 馬普科技促進協會
Publication of HK1192322A1 publication Critical patent/HK1192322A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK14105616.7A 2010-12-21 2014-06-13 Determination of the efficacy of an anti mycobacterial vaccination HK1192322A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061425442P 2010-12-21 2010-12-21
PCT/EP2011/073609 WO2012085099A1 (en) 2010-12-21 2011-12-21 Determination of the efficacy of an anti-mycobacterial vaccination

Publications (1)

Publication Number Publication Date
HK1192322A1 true HK1192322A1 (en) 2014-08-15

Family

ID=45446021

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14105616.7A HK1192322A1 (en) 2010-12-21 2014-06-13 Determination of the efficacy of an anti mycobacterial vaccination

Country Status (25)

Country Link
US (1) US8906389B2 (ja)
EP (1) EP2656070B9 (ja)
JP (1) JP6055780B2 (ja)
KR (1) KR101882040B1 (ja)
CN (1) CN103492877B (ja)
AU (1) AU2011347266B2 (ja)
BR (1) BR112013015878B1 (ja)
CA (1) CA2822715C (ja)
CU (1) CU20130084A7 (ja)
CY (1) CY1117412T1 (ja)
DK (1) DK2656070T3 (ja)
EA (1) EA029833B9 (ja)
ES (1) ES2569035T3 (ja)
HK (1) HK1192322A1 (ja)
HR (1) HRP20160558T1 (ja)
HU (1) HUE027781T2 (ja)
MX (1) MX345961B (ja)
PL (1) PL2656070T3 (ja)
PT (1) PT2656070E (ja)
RS (1) RS54770B1 (ja)
SG (1) SG191331A1 (ja)
SI (1) SI2656070T1 (ja)
SM (1) SMT201600149B (ja)
UA (2) UA113282C2 (ja)
WO (1) WO2012085099A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3543698A1 (en) * 2018-03-20 2019-09-25 Helmholtz-Zentrum für Infektionsforschung GmbH Method for determining vaccine efficacy in an individual and means therefore

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0902086A1 (en) 1997-08-22 1999-03-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine
EP1137769B1 (en) * 1998-11-10 2008-09-03 University Of Rochester Methods for the generation of dna libraries
GB9923309D0 (en) * 1999-10-01 1999-12-08 Glaxo Group Ltd Assay
JP2001215224A (ja) * 1999-11-25 2001-08-10 Hitachi Chem Co Ltd 免疫反応のアッセイ法、免疫学的判定法及びアッセイキット
CA2523084C (en) 2003-04-23 2012-09-04 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Tuberculosis vaccine with improved efficacy
AU2006214473A1 (en) * 2005-02-14 2006-08-24 Wyeth Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor
US20080031882A1 (en) * 2006-06-19 2008-02-07 Liang Spencer C Methods of modulating IL-22 and IL-17
CN101329230B (zh) * 2008-07-14 2010-10-20 中国人民解放军第三军医大学 改进的免疫荧光细胞染色方法
JP2010051307A (ja) * 2008-07-28 2010-03-11 Eisai R & D Management Co Ltd Ｔｈ１７細胞およびＴｒｅｇ細胞の分化誘導を調節する物質のスクリーニング方法
DK2341928T3 (en) * 2008-10-20 2015-09-28 Univ Zürich MYCOBACTERIUM TUBERCULOSIS VACCINE
BRPI1011919A2 (pt) * 2009-06-29 2017-09-26 Childrens Medical Center vacinas e composições contra streptococcus pneumoniae

Also Published As

Publication number Publication date
CU20130084A7 (es) 2013-12-27
KR20140020243A (ko) 2014-02-18
SG191331A1 (en) 2013-07-31
US8906389B2 (en) 2014-12-09
PT2656070E (pt) 2016-06-17
WO2012085099A1 (en) 2012-06-28
BR112013015878B1 (pt) 2020-10-27
US20130280739A1 (en) 2013-10-24
AU2011347266A1 (en) 2013-07-25
SMT201600149B (it) 2016-07-01
UA112067C2 (uk) 2016-07-25
EP2656070B9 (en) 2017-01-04
ES2569035T3 (es) 2016-05-06
CN103492877B (zh) 2015-04-01
HRP20160558T1 (hr) 2016-06-17
EA029833B1 (ru) 2018-05-31
SI2656070T1 (sl) 2016-05-31
JP2014502841A (ja) 2014-02-06
DK2656070T3 (en) 2016-06-13
CA2822715A1 (en) 2012-06-28
KR101882040B1 (ko) 2018-07-25
UA113282C2 (xx) 2017-01-10
JP6055780B2 (ja) 2016-12-27
CA2822715C (en) 2019-04-30
BR112013015878A2 (pt) 2016-10-04
EP2656070B1 (en) 2016-03-09
EA201300738A1 (ru) 2013-12-30
HUE027781T2 (en) 2016-11-28
MX345961B (es) 2017-02-28
MX2013007244A (es) 2014-01-17
EA029833B9 (ru) 2018-06-29
RS54770B1 (sr) 2016-10-31
CY1117412T1 (el) 2017-04-26
AU2011347266B2 (en) 2016-07-21
EP2656070A1 (en) 2013-10-30
PL2656070T3 (pl) 2017-01-31
CN103492877A (zh) 2014-01-01

Similar Documents

Publication Publication Date Title
IL221503A (en) A system for increasing the overall diameter of veins
GB201010196D0 (en) Methods
PL2528621T3 (pl) Zmodyfikowane antygeny gruźlicy
HUE051199T2 (hu) Módosított anti-CD-4 antitestek
PL2552212T3 (pl) Ulepszona postać preparatu
EP2660945A4 (en) CHARGING DEVICE
EP2531023A4 (en) ENHANCED FORMULATION
GB2479724B (en) Umbilical
GB2479725B (en) Umbilical
GB201014965D0 (en) Vaccine
GB201007944D0 (en) Methods
GB201002409D0 (en) Methods
HK1192322A1 (en) Determination of the efficacy of an anti mycobacterial vaccination
GB201006324D0 (en) Vaccine
GB201004270D0 (en) Stinger deploymen device
ZA201302154B (en) Vaccine
PL120153U1 (pl) Zatyczka uniwersalna
GB201015567D0 (en) Methods
GB201011010D0 (en) Methods
GB2483644B (en) Electro-mechanical interface
AU2010900419A0 (en) Combination vaccines
AU2010900378A0 (en) An Improved Device
GB201012283D0 (en) Vaccine
GB201007589D0 (en) Vaccine
GB201007588D0 (en) Vaccine